Yahoo Finance • 2 months ago
PacBio Highly Accurate Long-Read Sequencing Data from Revio will Support Germany’s National Genome Initiative and Provide Data to the International Male Infertility Consortium MENLO PARK, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- PacBio... Full story
Yahoo Finance • 8 months ago
In this article, we will be taking a look at 11 oversold NASDAQ stocks to buy right now. To skip our detailed analysis of current stock market news, you can go directly to see the 5 Oversold NASDAQ Stocks To Buy Right Now. NASDAQ Leads Th... Full story
Yahoo Finance • 8 months ago
In this piece, we will take a look at the 14 best beaten down stocks to buy right now. If you want to skip our coverage of the latest events in the stock market, then you can take a look at the 5 Best Beaten Down Stocks To Buy Right Now.... Full story
Yahoo Finance • 9 months ago
In this article, we discuss the top 11 CRISPR stocks to invest in. If you want to skip our discussion of the gene editing industry, head directly to Top 5 CRISPR Stocks To Invest In. Genome editing refers to a set of technologies enabling... Full story
Yahoo Finance • 9 months ago
New Library Preparation Solutions Offer Never Before Achieved Scale for the Revio™ Sequencing System MENLO PARK, Calif., Feb. 5, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing s... Full story
Yahoo Finance • 10 months ago
In this piece, we will take a look at the 12 most promising gene editing stocks according to hedge funds. If you want to skip our take on how the gene editing industry sits right at the top of the global innovation food chain, then you can... Full story
Yahoo Finance • 11 months ago
In this piece, we will take a look at the 12 best genomics stocks to buy now. If you want to skip our introduction to the genomics industry and all the latest trends, then take a look at 5 Best Genomics Stocks To Buy Now. If there's one t... Full story
Yahoo Finance • last year
Is Pacific Biosciences of California Stock A Buy? Pacific Biosciences of California stock is not currently near a potential buy zone. Pacific Biosciences of California stock earns the No. 19 rank among its peers in the Medical-Systems/Equi... Full story
Yahoo Finance • last year
MENLO PARK, Calif., June 26, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. ("PacBio") (NASDAQ: PACB) today announced that it has entered into a privately negotiated exchange agreement with a holder of PacBio's outstanding 1.... Full story
Yahoo Finance • last year
In this article, we discuss 10 DNA stocks that billionaires love. If you want to skip our detailed analysis of the DNA market, head over to 5 DNA Stocks Billionaires Are Loading Up On. Genomics is the study of a complete set of DNA within... Full story
Yahoo Finance • 2 years ago
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2023 Earnings Call Transcript May 2, 2023 Operator: Good day and welcome to the PacBio First Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. Aft... Full story
Yahoo Finance • 2 years ago
In this article, we discuss the top 10 CRISPR stocks to buy. If you want to see more stocks in this selection, check out Top 5 CRISPR Stocks To Buy. Molecular biology, genetics, and genomics are in a significant period in history where te... Full story
Yahoo Finance • 2 years ago
Buying shares in the best businesses can build meaningful wealth for you and your family. While not every stock performs well, when investors win, they can win big. Don't believe it? Then look at the Pacific Biosciences of California, Inc.... Full story
Yahoo Finance • 2 years ago
Market forces rained on the parade of Pacific Biosciences of California, Inc. (NASDAQ:PACB) shareholders today, when the analysts downgraded their forecasts for this year. Revenue estimates were cut sharply as analysts signalled a weaker o... Full story
Yahoo Finance • 2 years ago
MENLO PARK, Calif., June 27, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors gr... Full story
Yahoo Finance • 2 years ago
CAMBRIDGE, United Kingdom, June 14, 2022 (GLOBE NEWSWIRE) -- Cambridge Epigenetix (CEGX), a life sciences tools and technology company which is revolutionizing genome sequencing, today announced the appointment of Peter J. Fromen as Chie... Full story
Yahoo Finance • 2 years ago
The art and science of stock market investing requires a tolerance for losing money on some of the shares you buy. But it should be a priority to avoid stomach churning catastrophes, wherever possible. It must have been painful to be a Pac... Full story
Yahoo Finance • 2 years ago
カリフォルニア州メンローパークおよび東京発, May 09, 2022 (GLOBE NEWSWIRE) -- 高品質・高精度のシーケンシングソリューションのリーディングカンパニーであるパックバイオ (PacBio) (NASDAQ: PACB) は、ゲノム解析企業である株式会社アイラック (iLAC, Inc.)、およびロボティック・バイオロジー・インスティテュート株式会社 (Robotic Biology Institute, Inc.) (RBI) と共同で、高度... Full story
Yahoo Finance • 2 years ago
MENLO PARK, Calif., TOKYO, May 09, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration with genome analysis company iLAC, Inc. (iLAC)... Full story
Yahoo Finance • 2 years ago
MENLO PARK, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- PacBio announced today that it will be participating in the upcoming BofA Securities 2022 Healthcare Conference in Las Vegas, Nevada. PacBio’s management is scheduled to present on Th... Full story